Cerebro-hepato-renal (Zellweger) syndrome, adrenoleukodystrophy, and Refsum's disease: Plasma changes and skin fibroblast phytanic acid oxidase

Summary

Cerebro-hepato-renal (Zellweger) syndrome, adrenoleukodystrophy, and Refsum's disease patients can be divided into at least five distinct groups, according to the nature of their plasma changes and their fibroblast phytanic acid oxidase activities. The biochemical changes in the plasma vary from an increase in a single metabolite or group of structurally related metabolites, such as in X-linked adrenoleukodystrophy (ALD) and classical Refsum's disease, to an increase in a number of structurally distinct metabolites, as in neonatal ALD/Zellweger syndrome, and infantile Refsum's disease. All patients, with the exception of those with the X-linked form of adrenoleukodystrophy are deficient in phytanic acid oxidase activity. The great similarity observed in neonatal adrenoleukodystrophy/Zellweger syndrome and infantile Refsum's disease suggests that the basic biochemical lesion in each may be similar or at least closely related.

This is a preview of subscription content, access via your institution.

References

  1. Berkovic SF, Zajac JD, Warburton DJ, Merory JD, Fellenberg AJ, Poulos A, Pollard AC (1983) Adrenomyeloneuropathy in clinical and biochemical diagnosis. Aust NZ J Med 13:594–600

    CAS  Article  Google Scholar 

  2. Borst P (1983) Animal peroxisomes (microbodies) lipid biosynthesis and the Zellweger syndrome. Trends Biochem Sci 8:269–272

    CAS  Article  Google Scholar 

  3. Brown FR, McAdams AJ, Cullins JW, Konkol R, Singh I, Moser AB, Moser HW (1982) Cerebro-hepato-renal (Zellweger) syndrome and neonatal adrenoleukodystrophy. Similarities in phenotype and accumulation of very long chain fatty acids. Johns Hopkins Med J 151:344–351

    PubMed  Google Scholar 

  4. Burton BK, Reed SP, Remy WT (1981) Hyperpipecolic acidemia: Clinical and biochemical observations in two male siblings. J Pediatr 99:729–734

    CAS  Article  Google Scholar 

  5. Danks DM, Tippett P, Adams C, Campbell P (1975) Cerebro-hepatorenal syndrome of Zellweger. A report of eight cases with comments upon the incidence, liver lesion and a fault in pipecolic acid metabolism. J Pediatr 86:328–387

    Article  Google Scholar 

  6. Eldjarn L, Stokke P, Try K (1975) Biochemical aspects of Refsum's disease and principles for the dietary treatment. In: Vinken PJ, Bruyn GW (eds) Handbook of clinical neurology. Metabolic disorders of the nervous system. North Holland Publishing, Amsterdam

    Google Scholar 

  7. Farrell K, Dimmick JE, Applegarth DA, Wong LE, Tze WJ, McCormich AQ, Jan JE, Moser HW (1983) Peroxisomal abnormalities in neonatal adrenoleukodystrophy. Ann Neurol 4:379–380

    Google Scholar 

  8. Folch J, Lees M, Sloane-Stanley J (1957) A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 226:497–509

    CAS  PubMed  Google Scholar 

  9. Gatfield PD, Taller E, Hinton GG, Wallace AC, Abdelnour GM, Haust MD (1968) Hyperpipecolatemia: A new metabolic disorder associated with neuropathy and hepatomegaly. Can Med Assoc J 99:1215–1233

    CAS  PubMed  PubMed Central  Google Scholar 

  10. Goldfischer S (1982) Peroxisomes and human metabolic diseases. The cerebro-hepato-renal syndrome (CHRS), cerebrotendinous xanthomatosis and Schilder's disease (adrenoleukodystrophy). Ann NY Acad Sci 386:526–529

    Article  Google Scholar 

  11. Hanson RF, Isenberg JN, Williams JC, Hackey D, Szczepanik P, Klein PD, Sharp HL (1975) The metabolism of 3α, 7α, 12α-trihydroxy-5B-cholestan-26-oic acid in two siblings with cholestasis due to intrahepatic duct abnormalities. J Clin Invest 56:577–587

    CAS  Article  Google Scholar 

  12. Hanson RF, Szcepanik-van Leeuwen P, Williams GC, Grabowski G, Sharp HL (1979) Defects of bile acid synthesis in Zellweger's syndrome. Science 203:1107–1108

    CAS  Article  Google Scholar 

  13. Heymans H, Bosch HVD, Schutgens RBH, Tegelaers WHH, Walther JV, Muller-Hocker J, Borst P (1984) Deficiency of plasmalogens in the cerebro-hepato-renal (Zellweger) syndrome. Eur J Pediatr 142:10–15

    CAS  Article  Google Scholar 

  14. Inomata M, Takaku F, Nagai Y, Saita M (1982) Assay of polyunsaturated fatty acids by argentation — thin layer chromatography using commercial thin-layer plates. Anal Biochem 125:197–202

    CAS  Article  Google Scholar 

  15. Jaffe R, Crumrine P, Hashida Y, Moser HW (1982) Neonatal adrenoleukodystrophy: Clinical, pathologic and biochemical delineation of a syndrome affecting both males and females. Am J Pathol 108:100–111

    CAS  PubMed  PubMed Central  Google Scholar 

  16. Kelley RI (1983) The cerebrohepatorenal syndrome of Zellweger, morphologic and metabolic aspects. Am J Med Genet 16:503–517

    CAS  Article  Google Scholar 

  17. Moser HW, Moser AB, Kawamura N, Murphy J, Suzuki K, Schaumburg H, Kishimoto Y (1980) Adrenoleukodystrophy: Elevated C26 fatty acid in cultured skin fibroblasts. Ann Neurol 7:542–549

    CAS  Article  Google Scholar 

  18. Moser HW, Moser AB, Frayer KK, Chen W, Schulman JD, O'Neill BP, Kishimoto Y (1981) Adrenoleukodystrophy: Increased plasma content of saturated very long chain fatty acids. Neurology (NY) 31:1241–1249

    CAS  Article  Google Scholar 

  19. Moser AB, Singh I, Brown FR, Solish GI, Kelley RI, Benke PJ, Moser HW (1984) The cerebrohepatorenal (Zellweger) syndrome: Increased levels and impaired degradation of very long chain fatty acids and their use in prenatal diagnosis. N Engl J Med 310:1141–1146

    CAS  Article  Google Scholar 

  20. Noetzel MJ, Clark B, Moser HW (1983) Neonatal adrenoleukodystrophy with prolonged survival. Ann Neurol 14:379–380

    Google Scholar 

  21. Oftebro H, Bjorkhem I, Skrede S, Schreiner A, Pedersen JI (1980) Cerebrotendinous xanthomatosis, a defect in mitochondrial 26-hydroxylation required for normal biosynthesis of cholic acid. J Clin Invest 65:1418–1430

    CAS  Article  Google Scholar 

  22. Poulos A (1981) Diagnosis of Refsum's disease using [1-14C] phytanic acid as substrate. Clin Genet 20:247–253

    CAS  Article  Google Scholar 

  23. Poulos A, Sharp P (1984) Plasma and skin fibroblasts C26 fatty acids in infantile Refsum's disease. Neurology (NY) 34:1606–1609

    CAS  Article  Google Scholar 

  24. Poulos A, Whiting M (to be published) Identification of 3,7,12-trihydroxy-5-cholestan-26-oic acid, and intermediate in cholic acid synthesis, in the plasma of patients with infantile Refsum's disease. J Inherited Metab Dis

  25. Poulos A, Sharp P, Whiting M (1984a) Infantile Refsum's disease (phytanic acid storage disease). A variant of Zellweger's syndrome? Clin Genet 26:579–586

    CAS  Article  Google Scholar 

  26. Poulos A, Pollard AC, Mitchell JD, Wise G, Mortimer G (1984b) Patterns of Refsum's disease. Phytanic acid oxidase deficiency. Arch Dis Child 59:222–229

    CAS  Article  Google Scholar 

  27. Refsum S (1975) Heredopathia atactica polyneuritiformis. Phytanic acid storage disease (Refsum's disease). In: Vinken PJ, Bruyn GW (eds) Handbook of clinical neurology: Metabolic disorders of the nervous system. North Holland Publishing, Amsterdam, pp 181–229

    Google Scholar 

  28. Schaumburg HH, Powers JM, Raine CS (1975) Adrenoleukodystrophy: A clinical and pathological study of 17 cases. Arch Neurol 32:577–591

    CAS  Article  Google Scholar 

  29. Schutgens RBH, Romeyn GJ, Wanders RJA, van den Bosch H, Schrakamp G, Heymans HSA (1984) Deficiency of acyl-CoA dihydroxyacetone phosphate acyltransferase in patients with Zellweger (cerebro-hepato-renal) syndrome. Biochem Biophys Res Commun 120:179–184

    CAS  Article  Google Scholar 

  30. Scotto JM, Hadchouel M, Odievre M, Laudat MH, Saudubray JM, Dulac P, Beucler I, Beaune P (1982) Infantile phytanic acid storage disease, a possible variant of Refsum's disease. Three cases including ultrastructural studies of the liver. J Inherited Metab Dis 5:83–90

    CAS  Article  Google Scholar 

  31. Singh I, Moser AE, Moser HW, Kishimoto Y (1984) Adrenoleukodystrophy—impaired oxidation of very long chain fatty acids in white blood cells, cultured skin fibroblasts and amniocytes. Pediatr Res 18:286–289

    CAS  Article  Google Scholar 

  32. Steinberg D (1978) Phytanic acid storage disease: Refsum's syndrome. In: Stanbury JB, Wyngaarden JB, Fredrickson DS (eds) The metabolic basis of inherited disease. McGraw-Hill Book Co, New York, pp 688–706

    Google Scholar 

  33. Thomas GH, Haslam RHA, Batshaw ML, Capute AJ, Niedengard L, Ransom JL (1975) Hyperpipecolic acidemia associated with hepatomegaly, mental retardation, optic dysplasia and progressive neurological disease. Clin Genet 8:376–382

    CAS  Article  Google Scholar 

  34. Tsai SC, Avigan J, Steinberg D (1969) Studies on the α-oxidation of phytanic acid by rat liver mitochondria. J Biol Chem 244:2628–2692

    Google Scholar 

  35. Woody NC, Pupene MB (1970) Excretion of pipecolic acid by infants and by patients with hyperlysinemia. Pediatr Res 4:89–95

    CAS  Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to A. Poulos.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Poulos, A., Sharp, P., Fellenberg, A.J. et al. Cerebro-hepato-renal (Zellweger) syndrome, adrenoleukodystrophy, and Refsum's disease: Plasma changes and skin fibroblast phytanic acid oxidase. Hum Genet 70, 172–177 (1985). https://doi.org/10.1007/BF00273077

Download citation

Keywords

  • Internal Medicine
  • Metabolic Disease
  • Disease Patient
  • Distinct Group
  • Phytanic Acid